IRTC - iRhythm climbs as Q2 tops estimates despite regulatory setback
2023-08-04 14:18:44 ET
More on iRhythm Technologies
- iRhythm Technologies, Inc. 2023 Q2 - Results - Earnings Call Presentation
- iRhythm Technologies: Unpacking The FDA Warning Letter
- iRhythm: Revolutionizing Arrhythmia Detection With AI And Machine Learning
- iRhythm is a new Outperform at Baird despite FDA warning letter
- iRhythm Technologies initiated at overweight at Wells Fargo on US market penetration
For further details see:
iRhythm climbs as Q2 tops estimates despite regulatory setback